{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:28:00Z","timestamp":1786670880943,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273084"],"award-info":[{"award-number":["82273084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08375-9","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:45:08Z","timestamp":1780915508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An epithelial cell fate-driven predictive model for liver metastasis risk in primary colorectal cancer through single-cell and multi-omics integration"],"prefix":"10.1186","volume":"24","author":[{"given":"Min","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-5696","authenticated-orcid":false,"given":"Yefei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"8375_CR1","first-page":"109","volume":"76","author":"Routine aspirin or","year":"2007","unstructured":"Routine aspirin or. nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: recommendation statement. Am Fam Physician. 2007;76:109\u201313.","journal-title":"Am Fam Physician"},{"key":"8375_CR2","first-page":"325","volume":"79","author":"KW Lin","year":"2009","unstructured":"Lin KW. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. Am Fam Physician. 2009;79:325\u20136.","journal-title":"Am Fam Physician"},{"key":"8375_CR3","doi-asserted-by":"publisher","first-page":"11645","DOI":"10.2147\/OTT.S271955","volume":"13","author":"X Yu","year":"2020","unstructured":"Yu X, Zhu L, Liu J, Xie M, Chen J, Li J. Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis. Onco Targets Ther. 2020;13:11645\u201358.","journal-title":"Onco Targets Ther"},{"key":"8375_CR4","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3892\/or.2017.5531","volume":"37","author":"MH Al Bandar","year":"2017","unstructured":"Al Bandar MH, Kim NK. Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review). Oncol Rep. 2017;37:2553\u201364.","journal-title":"Oncol Rep"},{"key":"8375_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789\u201399.","journal-title":"Nat Med"},{"key":"8375_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00428-016-1956-3","volume":"469","author":"MF M\u00fcller","year":"2016","unstructured":"M\u00fcller MF, Ibrahim AE, Arends MJ. Molecular pathological classification of colorectal cancer. Virchows Arch. 2016;469:125\u201334.","journal-title":"Virchows Arch"},{"key":"8375_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","volume":"14","author":"CJ Punt","year":"2017","unstructured":"Punt CJ, Koopman M, Vermeulen L. From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat Rev Clin Oncol. 2017;14:235\u201346.","journal-title":"Nat Rev Clin Oncol"},{"key":"8375_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.semcancer.2018.05.002","volume":"55","author":"W Wang","year":"2019","unstructured":"Wang W, Kandimalla R, Huang H, Zhu L, Li Y, Gao F, Goel A, Wang X. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities. Semin Cancer Biol. 2019;55:37\u201352.","journal-title":"Semin Cancer Biol"},{"key":"8375_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ccell.2020.09.015","volume":"38","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Bian S, Zhou X, Cui Y, Wang W, Wen L, Guo L, Fu W, Tang F. Single-Cell Multiomics Sequencing Reveals Prevalent Genomic Alterations in Tumor Stromal Cells of Human Colorectal Cancer. Cancer Cell. 2020;38:818\u2013e828815.","journal-title":"Cancer Cell"},{"key":"8375_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1672-7","volume":"574","author":"H Lee-Six","year":"2019","unstructured":"Lee-Six H, Olafsson S, Ellis P, Osborne RJ, Sanders MA, Moore L, Georgakopoulos N, Torrente F, Noorani A, Goddard M, et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature. 2019;574:532\u20137.","journal-title":"Nature"},{"key":"8375_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","volume":"54","author":"I Joanito","year":"2022","unstructured":"Joanito I, Wirapati P, Zhao N, Nawaz Z, Yeo G, Lee F, Eng CLP, Macalinao DC, Kahraman M, Srinivasan H, et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat Genet. 2022;54:963\u201375.","journal-title":"Nat Genet"},{"key":"8375_CR12","doi-asserted-by":"publisher","first-page":"goad034","DOI":"10.1093\/gastro\/goad034","volume":"11","author":"H Ke","year":"2023","unstructured":"Ke H, Li Z, Li P, Ye S, Huang J, Hu T, Zhang C, Yuan M, Chen Y, Wu X, Lan P. Dynamic heterogeneity of colorectal cancer during progression revealed clinical risk-associated cell types and regulations in single-cell resolution and spatial context. Gastroenterol Rep (Oxf). 2023;11:goad034.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"8375_CR13","doi-asserted-by":"publisher","first-page":"e70175","DOI":"10.1002\/ctm2.70175","volume":"15","author":"H Ke","year":"2025","unstructured":"Ke H, Li P, Li Z, Zeng X, Zhang C, Luo S, Chen X, Zhou X, Dong S, Chen S, et al. Immune profiling of the macroenvironment in colorectal cancer unveils systemic dysfunction and plasticity of immune cells. Clin Transl Med. 2025;15:e70175.","journal-title":"Clin Transl Med"},{"key":"8375_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1126\/science.aau3429","volume":"365","author":"D Krndija","year":"2019","unstructured":"Krndija D, El Marjou F, Guirao B, Richon S, Leroy O, Bellaiche Y, Hannezo E, Matic Vignjevic D. Active cell migration is critical for steady-state epithelial turnover in the gut. Science. 2019;365:705\u201310.","journal-title":"Science"},{"key":"8375_CR15","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1158\/0008-5472.CAN-17-0327","volume":"77","author":"S Mei","year":"2017","unstructured":"Mei S, Meyer CA, Zheng R, Qin Q, Wu Q, Jiang P, Li B, Shi X, Wang B, Fan J, et al. Cistrome Cancer: A Web Resource for Integrative Gene Regulation Modeling in Cancer. Cancer Res. 2017;77:e19\u201322.","journal-title":"Cancer Res"},{"key":"8375_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1053\/j.gastro.2020.09.032","volume":"160","author":"AA May-Zhang","year":"2021","unstructured":"May-Zhang AA, Tycksen E, Southard-Smith AN, Deal KK, Benthal JT, Buehler DP, Adam M, Simmons AJ, Monaghan JR, Matlock BK, et al. Combinatorial Transcriptional Profiling of Mouse and Human Enteric Neurons Identifies Shared and Disparate Subtypes In Situ. Gastroenterology. 2021;160:755\u2013e770726.","journal-title":"Gastroenterology"},{"key":"8375_CR17","doi-asserted-by":"crossref","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, Satija R. Comprehensive Integration of Single-Cell Data. Cell. 2019;177:1888\u2013e19021821.","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"8375_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/bioinformatics\/btu674","volume":"31","author":"NC Chung","year":"2015","unstructured":"Chung NC, Storey JD. Statistical significance of variables driving systematic variation in high-dimensional data. Bioinformatics. 2015;31:545\u201354.","journal-title":"Bioinformatics"},{"key":"8375_CR19","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, Luo T, Xu L, Liao G, Yan M, et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47:D721\u20138.","journal-title":"Nucleic Acids Res"},{"key":"8375_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163\u201372.","journal-title":"Nat Immunol"},{"key":"8375_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/bioinformatics\/btu589","volume":"31","author":"Y Pomyen","year":"2015","unstructured":"Pomyen Y, Segura M, Ebbels TM, Keun HC. Over-representation of correlation analysis (ORCA): a method for identifying associations between variable sets. Bioinformatics. 2015;31:102\u20138.","journal-title":"Bioinformatics"},{"key":"8375_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"8375_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"8375_CR24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14:979\u201382.","journal-title":"Nat Methods"},{"key":"8375_CR25","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"8375_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nbt0308-303","volume":"26","author":"M Ringn\u00e9r","year":"2008","unstructured":"Ringn\u00e9r M. What is principal component analysis? Nat Biotechnol. 2008;26:303\u20134.","journal-title":"Nat Biotechnol"},{"key":"8375_CR27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W. Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"8375_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"8375_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18:248\u201362.","journal-title":"Cell Rep"},{"key":"8375_CR30","doi-asserted-by":"crossref","unstructured":"Gustavsen JA, Pai S, Isserlin R, Demchak B, Pico AR. RCy3: Network biology using cytoscape from within R. F1000Res 2019, 8:1774.","DOI":"10.12688\/f1000research.20887.1"},{"key":"8375_CR31","doi-asserted-by":"publisher","first-page":"114579","DOI":"10.1016\/j.intimp.2025.114579","volume":"155","author":"J Liu","year":"2025","unstructured":"Liu J, Su Y, Zhang C, Dong H, Yu R, Yang X, Tian Y, Feng Y, Zhang J, Shi M, et al. NCOA3 impairs the efficacy of anti-PD-L1 therapy via HSP90\u03b1\/EZH2\/CXCL9 axis in colon cancer. Int Immunopharmacol. 2025;155:114579.","journal-title":"Int Immunopharmacol"},{"key":"8375_CR32","doi-asserted-by":"publisher","first-page":"217007","DOI":"10.1016\/j.canlet.2024.217007","volume":"597","author":"M Yuan","year":"2024","unstructured":"Yuan M, Zhang C, Chen S, Ye S, Liu H, Ke H, Huang J, Liang G, Yu R, Hu T, et al. PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1. Cancer Lett. 2024;597:217007.","journal-title":"Cancer Lett"},{"key":"8375_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D, Cheng Y, Huang S, Liu Y, Jiang S, et al. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. Cancer Discov. 2022;12:134\u201353.","journal-title":"Cancer Discov"},{"key":"8375_CR34","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871\u201390.","journal-title":"Cell"},{"key":"8375_CR35","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1387\/ijdb.072410mn","volume":"53","author":"MA Nieto","year":"2009","unstructured":"Nieto MA. Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives. Int J Dev Biol. 2009;53:1541\u20137.","journal-title":"Int J Dev Biol"},{"key":"8375_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8375_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature21713","volume":"543","author":"F de Sousa e Melo","year":"2017","unstructured":"de Sousa e Melo F, Kurtova AV, Harnoss JM, Kljavin N, Hoeck JD, Hung J, Anderson JE, Storm EE, Modrusan Z, Koeppen H, et al. A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer. Nature. 2017;543:676\u201380.","journal-title":"Nature"},{"key":"8375_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2020.02.008","volume":"26","author":"A Fumagalli","year":"2020","unstructured":"Fumagalli A, Oost KC, Kester L, Morgner J, Bornes L, Bruens L, Spaargaren L, Azkanaz M, Schelfhorst T, Beerling E, et al. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell Stem Cell. 2020;26:569\u2013e578567.","journal-title":"Cell Stem Cell"},{"key":"8375_CR39","doi-asserted-by":"publisher","first-page":"55663","DOI":"10.18632\/oncotarget.10971","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Zhang Y, Zhao Y, Liang Y, Xiang C, Zhou H, Zhang H, Zhang Q, Qing H, Jiang B, et al. CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3\/VEGF signaling pathway in colorectal cancer. Oncotarget. 2016;7:55663\u201376.","journal-title":"Oncotarget"},{"key":"8375_CR40","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/oby.20212","volume":"21","author":"RM Bove","year":"2013","unstructured":"Bove RM, Brick DJ, Healy BC, Mancuso SM, Gerweck AV, Bredella MA, Sherman JC, Miller KK. Metabolic and endocrine correlates of cognitive function in healthy young women. Obes (Silver Spring). 2013;21:1343\u20139.","journal-title":"Obes (Silver Spring)"},{"key":"8375_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13046-019-1375-9","volume":"38","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Li Y, Sheng J, Wu F, Li K, Huang R, Wang X, Jiao T, Guan X, Lu Y, et al. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. J Exp Clin Cancer Res. 2019;38:379.","journal-title":"J Exp Clin Cancer Res"},{"key":"8375_CR42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","volume":"14","author":"SP Patel","year":"2015","unstructured":"Patel SP, Kurzrock R. PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy. Mol Cancer Ther. 2015;14:847\u201356.","journal-title":"Mol Cancer Ther"},{"key":"8375_CR43","doi-asserted-by":"publisher","first-page":"103147","DOI":"10.1016\/j.critrevonc.2020.103147","volume":"157","author":"PG Alexander","year":"2021","unstructured":"Alexander PG, McMillan DC, Park JH. A meta-analysis of CD274 (PD-L1) assessment and prognosis in colorectal cancer and its role in predicting response to anti-PD-1 therapy. Crit Rev Oncol Hematol. 2021;157:103147.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8375_CR44","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1111\/cas.14969","volume":"112","author":"Y Kobayashi","year":"2021","unstructured":"Kobayashi Y, Masuda T, Fujii A, Shimizu D, Sato K, Kitagawa A, Tobo T, Ozato Y, Saito H, Kuramitsu S, et al. Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer. Cancer Sci. 2021;112:3173\u201389.","journal-title":"Cancer Sci"},{"key":"8375_CR45","doi-asserted-by":"publisher","first-page":"166281","DOI":"10.1016\/j.bbadis.2021.166281","volume":"1868","author":"S Pan","year":"2022","unstructured":"Pan S, Guo Y, Hong F, Xu P, Zhai Y. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166281.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"8375_CR46","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1002\/jcp.30132","volume":"236","author":"MA Vostakolaei","year":"2021","unstructured":"Vostakolaei MA, Hatami-Baroogh L, Babaei G, Molavi O, Kordi S, Abdolalizadeh J. Hsp70 in cancer: A double agent in the battle between survival and death. J Cell Physiol. 2021;236:3420\u201344.","journal-title":"J Cell Physiol"},{"key":"8375_CR47","doi-asserted-by":"publisher","first-page":"nwab014","DOI":"10.1093\/nsr\/nwab014","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang X, Wang Y, Fang Z, Wang H, Zhang J, Zhang L, Huang H, Jiang Z, Jin Y, Han X, et al. Targeting HSPA1A in ARID2-deficient lung adenocarcinoma. Natl Sci Rev. 2021;8:nwab014.","journal-title":"Natl Sci Rev"},{"key":"8375_CR48","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/hep.32444","volume":"76","author":"Y He","year":"2022","unstructured":"He Y, Luo J, Zhang G, Jin Y, Wang N, Lu J, Li C, Guo X, Qin N, Dai J, Chen Y. Single-cell profiling of human CD127(+) innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma. Hepatology. 2022;76:1013\u201329.","journal-title":"Hepatology"},{"key":"8375_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2011.11.020","volume":"317","author":"FH Wu","year":"2012","unstructured":"Wu FH, Yuan Y, Li D, Liao SJ, Yan B, Wei JJ, Zhou YH, Zhu JH, Zhang GM, Feng ZH. Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance. Cancer Lett. 2012;317:157\u201364.","journal-title":"Cancer Lett"},{"key":"8375_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12935-021-01987-9","volume":"21","author":"B Wang","year":"2021","unstructured":"Wang B, Lan T, Xiao H, Chen ZH, Wei C, Chen LF, Guan JF, Yuan RF, Yu X, Hu ZG, et al. The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma. Cancer Cell Int. 2021;21:286.","journal-title":"Cancer Cell Int"},{"key":"8375_CR51","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","volume":"10","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Giacomantonio CA, Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle. 2011;10:1378\u201384.","journal-title":"Cell Cycle"},{"key":"8375_CR52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/1878-0261.13528","volume":"18","author":"AG Bharadwaj","year":"2024","unstructured":"Bharadwaj AG, McLean ME, Dahn ML, Cahill HF, Wasson MD, Arun RP, Walker OL, Cruickshank BM, Fernando W, Venkatesh J, et al. ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway. Mol Oncol. 2024;18:91\u2013112.","journal-title":"Mol Oncol"},{"key":"8375_CR53","doi-asserted-by":"crossref","unstructured":"McLean ME, MacLean MR, Cahill HF, Arun RP, Walker OL, Wasson MD, Fernando W, Venkatesh J, Marcato P. The expanding role of cancer stem cell marker ALDH1A3 in cancer and beyond. Cancers (Basel) 2023, 15.","DOI":"10.3390\/cancers15020492"},{"key":"8375_CR54","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/ijc.30091","volume":"139","author":"JJ Duan","year":"2016","unstructured":"Duan JJ, Cai J, Guo YF, Bian XW, Yu SC. ALDH1A3, a metabolic target for cancer diagnosis and therapy. Int J Cancer. 2016;139:965\u201375.","journal-title":"Int J Cancer"},{"key":"8375_CR55","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fonc.2020.00915","volume":"10","author":"S Nie","year":"2020","unstructured":"Nie S, Qian X, Shi M, Li H, Peng C, Ding X, Zhang S, Zhang B, Xu G, Lv Y, et al. ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism. Front Oncol. 2020;10:915.","journal-title":"Front Oncol"},{"key":"8375_CR56","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1172\/JCI126414","volume":"129","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang HW, Wang S, Fan L, Feng S, Cai X, Peng C, Wu X, Lu J, Chen D, et al. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells. J Clin Invest. 2019;129:2043\u201355.","journal-title":"J Clin Invest"},{"key":"8375_CR57","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1158\/1535-7163.MCT-19-0461","volume":"19","author":"D Yamashita","year":"2020","unstructured":"Yamashita D, Minata M, Ibrahim AN, Yamaguchi S, Coviello V, Bernstock JD, Harada S, Cerione RA, Tannous BA, La Motta C, Nakano I. Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating Cells. Mol Cancer Ther. 2020;19:1134\u201347.","journal-title":"Mol Cancer Ther"},{"key":"8375_CR58","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1097-2765(00)00071-X","volume":"6","author":"S Gaubatz","year":"2000","unstructured":"Gaubatz S, Lindeman GJ, Ishida S, Jakoi L, Nevins JR, Livingston DM, Rempel RE. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell. 2000;6:729\u201335.","journal-title":"Mol Cell"},{"key":"8375_CR59","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/nature07066","volume":"454","author":"SY Tsai","year":"2008","unstructured":"Tsai SY, Opavsky R, Sharma N, Wu L, Naidu S, Nolan E, Feria-Arias E, Timmers C, Opavska J, de Bruin A, et al. Mouse development with a single E2F activator. Nature. 2008;454:1137\u201341.","journal-title":"Nature"},{"key":"8375_CR60","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1172\/JCI85506","volume":"126","author":"LN Kent","year":"2016","unstructured":"Kent LN, Rakijas JB, Pandit SK, Westendorp B, Chen HZ, Huntington JT, Tang X, Bae S, Srivastava A, Senapati S, et al. E2f8 mediates tumor suppression in postnatal liver development. J Clin Invest. 2016;126:2955\u201369.","journal-title":"J Clin Invest"},{"key":"8375_CR61","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1172\/JCI87583","volume":"127","author":"LN Kent","year":"2017","unstructured":"Kent LN, Bae S, Tsai SY, Tang X, Srivastava A, Koivisto C, Martin CK, Ridolfi E, Miller GC, Zorko SM, et al. Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. J Clin Invest. 2017;127:830\u201342.","journal-title":"J Clin Invest"},{"key":"8375_CR62","doi-asserted-by":"publisher","first-page":"8330","DOI":"10.1038\/s41598-018-26613-z","volume":"8","author":"W Lan","year":"2018","unstructured":"Lan W, Bian B, Xia Y, Dou S, Gayet O, Bigonnet M, Santofimia-Casta\u00f1o P, Cong M, Peng L, Dusetti N, Iovanna J. E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments. Sci Rep. 2018;8:8330.","journal-title":"Sci Rep"},{"key":"8375_CR63","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19:326\u201338.","journal-title":"Nat Rev Cancer"},{"key":"8375_CR64","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2018.11.019","volume":"443","author":"B Xie","year":"2019","unstructured":"Xie B, Wang S, Jiang N, Li JJ. Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett. 2019;443:56\u201366.","journal-title":"Cancer Lett"},{"key":"8375_CR65","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.18632\/aging.102254","volume":"11","author":"EB Chen","year":"2019","unstructured":"Chen EB, Qin X, Peng K, Li Q, Tang C, Wei YC, Yu S, Gan L, Liu TS. HnRNPR-CCNB1\/CENPF axis contributes to gastric cancer proliferation and metastasis. Aging. 2019;11:7473\u201391.","journal-title":"Aging"},{"key":"8375_CR66","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1111\/jog.13701","volume":"44","author":"I Mert","year":"2018","unstructured":"Mert I, Walther-Antonio M, Mariani A. Case for a role of the microbiome in gynecologic cancers: Clinician\u2019s perspective. J Obstet Gynaecol Res. 2018;44:1693\u2013704.","journal-title":"J Obstet Gynaecol Res"},{"key":"8375_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s10020-020-00161-7","volume":"26","author":"C Meng","year":"2020","unstructured":"Meng C, Zou Y, Hong W, Bao C, Jia X. Estrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression. Mol Med. 2020;26:33.","journal-title":"Mol Med"},{"key":"8375_CR68","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/neuonc\/noy207","volume":"21","author":"T Zhi","year":"2019","unstructured":"Zhi T, Jiang K, Xu X, Yu T, Zhou F, Wang Y, Liu N, Zhang J. ECT2\/PSMD14\/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1. Neuro Oncol. 2019;21:462\u201373.","journal-title":"Neuro Oncol"},{"key":"8375_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mcp.2017.11.004","volume":"37","author":"G Shi","year":"2018","unstructured":"Shi G, Wang Y, Zhang C, Zhao Z, Sun X, Zhang S, Fan J, Zhou C, Zhang J, Zhang H, Liu J. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling. Mol Cell Probes. 2018;37:39\u201347.","journal-title":"Mol Cell Probes"},{"key":"8375_CR70","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1038\/s41388-022-02402-x","volume":"41","author":"A You","year":"2022","unstructured":"You A, Tian W, Yuan H, Gu L, Zhou J, Deng D. TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern. Oncogene. 2022;41:3925\u201338.","journal-title":"Oncogene"},{"key":"8375_CR71","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/03602532.2016.1188939","volume":"48","author":"J Guo","year":"2016","unstructured":"Guo J, Johansson I, Mkrtchian S, Ingelman-Sundberg M. The CYP2W1 enzyme: regulation, properties and activation of prodrugs. Drug Metab Rev. 2016;48:369\u201378.","journal-title":"Drug Metab Rev"},{"key":"8375_CR72","doi-asserted-by":"publisher","first-page":"16217","DOI":"10.18632\/oncotarget.7479","volume":"7","author":"X He","year":"2016","unstructured":"He X, Li Y, Dai MS, Sun XX. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop. Oncotarget. 2016;7:16217\u201326.","journal-title":"Oncotarget"},{"key":"8375_CR73","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1038\/s41598-018-21048-y","volume":"8","author":"Y Gao","year":"2018","unstructured":"Gao Y, Wang J, Zhou Y, Sheng S, Qian SY, Huo X. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Sci Rep. 2018;8:2732.","journal-title":"Sci Rep"},{"key":"8375_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12935-018-0715-8","volume":"18","author":"W Tor\u00e9n","year":"2018","unstructured":"Tor\u00e9n W, Ansari D, Andersson R. Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis. Cancer Cell Int. 2018;18:217.","journal-title":"Cancer Cell Int"},{"key":"8375_CR75","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325:669\u201385.","journal-title":"JAMA"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08375-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:02:16Z","timestamp":1786669336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8375"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08375-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board for Clinical Research of Affiliated Hospital of Yangzhou University (2024-YKL05-KE02) and the Institutional Review Board of Yangzhou University (YXYLL-2021-18). Written informed consent was obtained from all patients. This study was in compliance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1052"}}